The functional impact of +1q, the most frequent genomic alteration in breast cancer (55–60% of patients), is more enigmatic, although some candidate drivers such as MDM4 (ref. 49), MCL1 (ref. 50), AKT3 (ref. 51) and KDM5B52 have been proposed. This evidence concerns the gene AKT3 and breast carcinoma.